Status:

COMPLETED

Increasing Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes.

Lead Sponsor:

Ottawa Hospital Research Institute

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Gestational Diabetes

Eligibility:

FEMALE

Phase:

NA

Brief Summary

In 1998, The Canadian Diabetes Association published guidelines that recommended women diagnosed with gestational diabetes mellitus (GDM,) should be screened postpartum for Type 2 diabetes using a glu...

Detailed Description

In 1998, the Canadian Diabetes Association (CDA) published guidelines that recommended all women diagnosed with gestational diabetes mellitus (GDM) should be screened 6 weeks to 6 months postpartum fo...

Eligibility Criteria

Inclusion

  • All women, who are pregnant and attend the High Risk Pregnancy Unit and who have been diagnosed with Gestational Diabetes will be considered for inclusion in the study.

Exclusion

  • 1\. Patient does not have a Family Physician 2. Patient's Family Physician already has a patient enrolled in the study 3. Patient already enrolled in the study for a previous pregnancy 4. Unable to give informed consent in English or French 5. History of pre-gestational diabetes mellitus 6. Intra-uterine fetal death or still birth

Key Trial Info

Start Date :

May 1 2002

Trial Type :

INTERVENTIONAL

End Date :

January 1 2006

Estimated Enrollment :

268 Patients enrolled

Trial Details

Trial ID

NCT00212914

Start Date

May 1 2002

End Date

January 1 2006

Last Update

September 9 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ottawa Hospital, Civic Campus, High Risk Unit

Ottawa, Ontario, Canada, K1Y 1J7